KLF7 and diabetes mellitus: Moreover, we demonstrate that miR-132-3p targets KLF7, which is upregulated in an in vitro model of diabetes-associated EndMT, during EndMT-triggered aortic stiffening in db/db mice as well as in aortas of diabetes patients.